Effects of sodium n-butyrate on alpha-fetoprotein and albumin secretion in the human hepatoma cell line PLC/PRF/5
1985
Effects of Sodium n-Butyrate on Liver Cancer Cells
publication
Evidence: moderate
Author Information
Author(s): T. Nakagawa, Y. Nakao, T. Matsui, T. Koizumi, S. Matsuda, S. Maeda, T. Fujita
Primary Institution: Kobe University School of Medicine
Hypothesis
How does sodium n-butyrate affect the growth and protein secretion of human hepatoma cells?
Conclusion
Sodium n-butyrate reduces the growth of hepatoma cells while increasing albumin secretion and decreasing alpha-fetoprotein levels.
Supporting Evidence
- Butyrate caused a marked reduction in the growth rate of PLC/PRF/5 cells.
- Secretion of alpha-fetoprotein was reduced while albumin secretion was increased in the presence of butyrate.
- The requirement of de novo protein synthesis for the increase in albumin and decrease of AFP by butyrate was demonstrated.
- Cells treated with butyrate showed significant morphological changes consistent with normal liver cells.
Takeaway
Sodium n-butyrate helps liver cancer cells act more like normal liver cells by slowing their growth and changing the proteins they produce.
Methodology
The study involved culturing human hepatoma cells and treating them with sodium n-butyrate, followed by measuring growth, protein secretion, and morphological changes.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Want to read the original?
Access the complete publication on the publisher's website